Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Pilot Study for the Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab Avastin or Ranibizumab Lucentis
Authors not listed
National Eye Institute (NEI) · 2008
Abstract
This study will measure antibody levels in the blood of people with bleeding or swelling in the retina who have or have not been treated with bevacizumab (Avastin\[Trademark\]or ranibizumab (Lucentis\[Trademark\]). These drugs have been useful in reducing retinal bleeding and swelling in people with eye diseases that cause these symptoms, but the drugs' effects usually wear off and they have to be given repeatedly. In some patients, the benefits become less and less. It is possible that over time, patients taking these drugs may produce antibodies that act against the drugs, thus neutralizing their effects and preventing them from working properly.
People 18 year of age and older who are participating in a current NEI protocol and meet the following criteria may be eligible for this study:
* Are receiving injections of bevacizumab or ranibizumab for bleeding or swelling in the retina, but the treatment is becoming less effective
* Are receiving injections of bevacizumab or ranibizumab for bleeding or swelling in the retina and the treatment is still effective
* Have bleeding or swelling in the retina, but have never received either bevacizumab or ranibizumab
Participants have blood samples drawn once when they start the study, once in the middle of the study, and once at the end of the study. They are asked permission for study researchers to review the results of their eye examinations at NIH.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2008). Pilot Study for the Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab Avastin or Ranibizumab Lucentis. <em>National Eye Institute (NEI)</em>. https://clinicaltrials.gov/study/NCT00605943
Vancouver
Anonymous. Pilot Study for the Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab Avastin or Ranibizumab Lucentis. National Eye Institute (NEI). 2008.
BibTeX
@misc{anon2008PilotS,
title = {Pilot Study for the Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab Avastin or Ranibizumab Lucentis},
author = {Anonymous},
journal = {National Eye Institute (NEI)},
year = {2008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
New England Journal of Medicine 2011
Open access · OA
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
The journal of nutrition health & aging 2015
Open access · OA
Predictors of frailty in old age–results of a longitudinal study
Istanbul Physical Medicine Rehabilitation Training and Research Hospital 2023
Open access · US-GOV
Evaluation of Sarcopenia in Patients Receiving Home Health Care
Claremont Graduate University 2010
Open access · US-GOV
Oxytocin and Social Behavior Over the Lifespan: Interventional Study
Unity Health Toronto 2017
Open access · US-GOV
Cytokine and Visual Outcome Variations in Eyes Receiving a Variable Dosing Aflibercept Treatment: The COVARIANT Study
BMC Geriatrics 2011
Open access · CC-BY